Northern Trust’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-360
Closed -$9.26K 4489
2024
Q4
$9.26K Hold
360
﹤0.01% 4425
2024
Q3
$14.5K Hold
360
﹤0.01% 4357
2024
Q2
$13.2K Sell
360
-1
-0.3% -$47 ﹤0.01% 4361
2024
Q1
$26.6K Hold
361
﹤0.01% 4308
2023
Q4
$31.9K Buy
361
+50
+16% +$4.76K ﹤0.01% 4311
2023
Q3
$29.4K Hold
311
﹤0.01% 4267
2023
Q2
$55.7K Hold
311
﹤0.01% 4199
2023
Q1
$81.6K Buy
311
+45
+17% +$8.92K ﹤0.01% 4129
2022
Q4
$41K Hold
266
﹤0.01% 4332
2022
Q3
$58K Buy
266
+70
+36% +$26.6K ﹤0.01% 4288
2022
Q2
$94K Buy
196
+14
+8% +$5.06K ﹤0.01% 4195
2022
Q1
$82K Buy
182
+2
+1% +$1.02K ﹤0.01% 4412
2021
Q4
$34K Buy
180
+81
+82% +$21.9K ﹤0.01% 4651
2021
Q3
$32K Buy
+99
New +$44.7K ﹤0.01% 4584

Other funds holding EDVA

Northern Trust's EDVA Position: Q1 2025 in Review

Northern Trust sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 360 shares — an estimated $9.26K sold.

Northern Trust first reported a position in EDVA in Q3 2021 and held it in 14 quarters. The position peaked at $94K in Q2 2022. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

  • Northern Trust reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 360 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $9.26K.
  • Northern Trust first reported a position in Endovia Health Sciences, Inc. in Q3 2021 and held it in 14 quarters.
  • Northern Trust's Endovia Health Sciences, Inc. position peaked at $94K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.